Get started
Author

Matthew Eximond

Observed name: M. Eximond
Observed institution: Lincoln Memorial University
ORCID: 0009-0006-3583-535X
Observed ORCID: 0009-0006-3583-535X
OpenAlex ID: A5092964972
Dual Immune Checkpoint Therapy Combined with Radiotherapy Treats Castration-Resistant Prostate Cancer
2023 · M. Eximond, J. Wang, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
PDF
Effects of Radiotherapy, Immune Checkpoint Inhibitors, and PIM Kinase Inhibition in Castration-Resistant Prostate Cancer
2026 · Vignesh Chennupati, Matthew Eximond, et al. · Current Cancer Drug Targets · 1
Abstract P1-08-16: Resolution of Active Pyoderma Gangrenosum during Adjuvant Breast Cancer Therapy: A Case Report
2025 · Abigail Lauder, Anita Nwiloh, et al. · Clinical Cancer Research
Resolution of Pyoderma Gangrenosum During Adjuvant Breast Cancer Therapy
2025 · Abigail P. Lauder, Anita Nwiloh, et al. · Journal of Clinical Medicine
PDF
Association of Prematurity and Urogenital Comorbidities with Postoperative Outcomes of Ureteroneocystostomy for Vesicoureteral Reflux
2023 · Raeann Dalton, Young Son, et al.
Works count: 5
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type